复方血栓通通过激活PPAR信号通路及补体与凝血级联缓解糖尿病视网膜病变
该研究以链脲佐菌素诱导的糖尿病大鼠模型观察复方血栓通(FXST)对视网膜的作用及机制。FXST灌胃12周可改善视网膜血流动力学、减轻结构紊乱与水肿、逆转视网膜厚度及神经节细胞数量下降并降低凋亡指数。RNA测序显示其作用与补体与凝血级联及PPAR信号通路相关。
要点
- FXST可改善糖尿病大鼠视网膜血流动力学及形态学改变。
- FXST降低视网膜神经细胞凋亡指数并逆转视网膜厚度与神经节细胞数量下降。
- 其机制涉及补体与凝血级联及PPAR信号通路的调控。
核心结论
- 复方血栓通通过改善糖尿病大鼠视网膜血流动力学和形态学改变来缓解糖尿病视网膜病变,该作用由补体与凝血级联及PPAR信号通路介导。
研究设计与样本
- 采用腹腔注射链脲佐菌素建立糖尿病大鼠模型,设正常组、糖尿病组和FXST组。
- FXST组经灌胃给予FXST治疗12周,其余组给予等体积生理盐水。
主要发现
- 糖尿病大鼠视网膜中央动脉峰值收缩速度、舒张末期速度和平均速度降低,阻力指数和搏动指数升高,FXST改善了血流动力学。
- 与糖尿病组相比,FXST减轻视网膜结构紊乱和水肿,逆转视网膜厚度和视网膜神经节细胞数量的下降,并降低视网膜细胞凋亡指数。
- RNA测序在FXST组对比糖尿病组中鉴定出1134个差异表达基因,其中814个上调、320个下调。
- 差异基因富集于补体与凝血级联以及过氧化物酶体增殖物激活受体(PPAR)信号通路。
- qRT-PCR验证了PPAR gamma、perilipin 4、酰基辅酶A脱氢酶长链、CD55分子和尿激酶型纤溶酶原激活物等差异基因,结果与RNA测序数据一致。
临床怎么用
- 复方血栓通作为已广泛用于糖尿病视网膜病变的中成药,本研究为其改善视网膜血流与结构提供了动物实验依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Fufang Xueshuantong (FXST) is a traditional Chinese patent medicine composed of Panax notoginseng (Burkill) F.H.Chen (Araliaceae), Salvia miltiorrhiza Bunge (Lamiaceae), Astragalus propinquus Schischkin (Leguminosae), and Scrophularia ningpoensis Hemsl. (Scrophulariaceae). It has been widely used for the treatment of diabetic retinopathy (DR) and exerts a positive clinical therapeutic effect. AIM OF THE STUDY: The aim of this study was to observe the effect of FXST on diabetic rat retinas and investigate its pharmacological mechanism for improving DR. METHODS: The diabetic rat model was established by intraperitoneal injection of streptozotocin. The rats were divided into a normal group, diabetic group, and FXST group. The rats in the FXST group were treated with FXST by intragastric administration for 12 weeks while other rats were given the same volume of normal saline. The haemodynamic parameters of the central retinal artery in the rats were measured by ultrasound. Haematoxylin-eosin staining was utilised to observe the pathological structural changes in the retina. The apoptosis of retinal nerve cells was detected by terminal deoxynucleotidyl transferase dUTP nick end labelling. RNA sequencing was used to screen the differentially expressed genes (DEGs), and enrichment analyses were performed. The DEGs were validated through real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). RESULTS: The peak systolic velocity, end diastolic velocity, and mean velocity decreased while the resistance index and pulsatility index increased in the diabetic rat retinas. FXST also improved haemodynamics. In contrast with the diabetic group, FXST allayed the disorder and oedema of the retinal structure in addition to reversing the reductions in retinal thickness and retinal ganglion cell number. It also decreased the apoptosis index of retinal cells. A total of 1134 DEGs were identified by RNA sequencing in the FXST group compared to the diabetic group, including 814 upregulated genes and 320 downregulated genes. These genes were enriched in the complement and coagulation cascades as well as the peroxisome proliferator-activated receptor (PPAR) signalling pathway. Several DEGs, including PPAR gamma, perilipin 4, acyl-CoA dehydrogenase long chain, CD55 molecule, and plasminogen activator urokinase, were identified by qRT-PCR, and the results were consistent with the RNA sequencing data. CONCLUSIONS: FXST alleviates DR by improving the haemodynamics and morphological alterations of diabetic rat retinas, which are mediated by complement and coagulation cascades and the PPAR signalling pathway.
引用
- Sun HH, Chai XL, Li HL, et al. Fufang Xueshuantong alleviates diabetic retinopathy by activating the PPAR signalling pathway and complement and coagulation cascades. J Ethnopharmacol. 2020. PMID: 32890714. doi:10.1016/j.jep.2020.113324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。